Kim-Anh Do
#64,914
Most Influential Person Now
Australian biostatistician
Kim-Anh Do's AcademicInfluence.com Rankings
Kim-Anh Domathematics Degrees
Mathematics
#4913
World Rank
#6939
Historical Rank
Statistics
#413
World Rank
#482
Historical Rank
Measure Theory
#2770
World Rank
#3308
Historical Rank
Download Badge
Mathematics
Kim-Anh Do's Degrees
- PhD Biostatistics University of Melbourne
- Masters Statistics University of Melbourne
- Bachelors Mathematics University of Melbourne
Similar Degrees You Can Earn
Why Is Kim-Anh Do Influential?
(Suggest an Edit or Addition)According to Wikipedia, Kim-Anh Do is an Australian biostatistician of Vietnamese descent. She is the chair of the Department of Biostatistics in the University of Texas MD Anderson Cancer Center, and the holder of the Electa C. Taylor Chair for Cancer Research at the center. She also holds adjunct professorships at Texas A&M University and Rice University.
Kim-Anh Do's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia. (2008) (714)
- Simplified staging for hepatocellular carcinoma. (2002) (667)
- Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. (2000) (618)
- Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes (2019) (597)
- Steps toward mapping the human vasculature by phage display (2002) (580)
- Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia. (2005) (535)
- Body surface area and body weight predict total liver volume in Western adults (2002) (530)
- Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer (2011) (520)
- CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. (2001) (482)
- Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells. (2016) (361)
- Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia. (2007) (340)
- Fingerprinting the circulating repertoire of antibodies from cancer patients (2003) (334)
- Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation. (2006) (247)
- Model-Based Clustering for Expression Data via a Dirichlet Process Mixture Model (2006) (218)
- Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significance. (2003) (217)
- PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3 (2015) (217)
- Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy (2006) (212)
- PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors (2012) (198)
- Preoperative Predictors of Survival After Resection of Small Hepatocellular Carcinomas (2002) (183)
- Longitudinal study of risk factors for coronary heart disease across the menopausal transition. (2000) (182)
- Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. (2001) (177)
- Bayesian inference for gene expression and proteomics (2006) (160)
- Reconstructive Management of Cranial Base Defects after Tumor Ablation (2001) (159)
- Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer (2012) (158)
- Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States) (2003) (152)
- Smoking and prostate cancer. (2001) (150)
- Factors Affecting the Decision of Breast Cancer Patients to Undergo Contralateral Prophylactic Mastectomy (2010) (144)
- Predictive factors of age at menopause in a large Australian twin study. (1998) (144)
- Association and Interactions between DNA Repair Gene Polymorphisms and Adult Glioma (2009) (142)
- Synchronous selection of homing peptides for multiple tissues by in vivo phage display (2006) (133)
- iBAG: integrative Bayesian analysis of high-dimensional multiplatform genomics data (2012) (131)
- Multivariable model for time to first treatment in patients with chronic lymphocytic leukemia. (2011) (129)
- Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL) (2002) (127)
- Longitudinal study of smoking patterns in relation to the development of smoking‐related secondary primary tumors in patients with upper aerodigestive tract malignancies (2004) (124)
- Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone (2006) (119)
- Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation (2019) (111)
- Treatment outcomes of small cell carcinoma of the prostate (2007) (108)
- Genetic influences on the age at menopause (1998) (107)
- DINGO: differential network analysis in genomics (2015) (105)
- Targeting platelet-derived growth factor receptor on endothelial cells of multidrug-resistant prostate cancer. (2006) (103)
- Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 years of experience at the University of Texas M.D. Anderson Cancer Center. (2007) (94)
- Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancer. (2011) (93)
- Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancer. (2008) (92)
- Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia. (2005) (87)
- Characteristics associated with important clinical end points in patients with chronic lymphocytic leukemia at initial treatment. (2009) (87)
- Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy. (2006) (86)
- Long-term results of first salvage treatment in CLL patients treated initially with FCR (fludarabine, cyclophosphamide, rituximab). (2014) (84)
- A Peptidomimetic Targeting White Fat Causes Weight Loss and Improved Insulin Resistance in Obese Monkeys (2011) (82)
- Ligand-directed surface profiling of human cancer cells with combinatorial peptide libraries. (2006) (80)
- Plasma interleukin 8 level predicts for survival in chronic lymphocytic leukaemia (2003) (78)
- Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. (2009) (77)
- Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti‐CD52 antibodies (2004) (75)
- A retrospective comparison of three sequential groups of patients with Recurrent/Refractory chronic lymphocytic leukemia treated with fludarabine‐based regimens (2006) (75)
- High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients (2012) (74)
- Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer†. (2014) (74)
- Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trial (2018) (73)
- Racial Disparity in Survival of Patients with Squamous Cell Carcinoma of the Oral Cavity and Pharynx (2001) (72)
- Serum Levels of Insulin Growth Factor (IGF-I) and IGF-Binding Protein Predict Risk of Second Primary Tumors in Patients with Head and Neck Cancer (2004) (71)
- Morphologic characterization of preoperatively treated prostate cancer: toward a post-therapy histologic classification. (2010) (70)
- Bayesian ensemble methods for survival prediction in gene expression data (2011) (69)
- Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma. (2004) (67)
- Gene Expression, Molecular Class Changes, and Pathway Analysis after Neoadjuvant Systemic Therapy for Breast Cancer (2012) (66)
- Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients (2011) (66)
- Predictors of hysterectomy: an Australian study. (1999) (65)
- Rapamycin Regulates Stearoyl CoA Desaturase 1 Expression in Breast Cancer (2010) (65)
- Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer (2012) (65)
- Birth weight and age at menopause in Australian female twin pairs: exploration of the fetal origin hypothesis. (2000) (64)
- Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers (2012) (64)
- Definition of Ross River Virus Vectors at Maroochy Shire, Australia (2000) (61)
- Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm. (2016) (61)
- Genetic analysis of the age at menopause by using estimating equations and Bayesian random effects models. (2000) (61)
- Cytoplasmic Sequestration of p27 via AKT Phosphorylation in Renal Cell Carcinoma (2009) (61)
- Gut Microbiome Signatures are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia. (2019) (56)
- Effect of Low-Fat Diets on Plasma Levels of NF-κB–Regulated Inflammatory Cytokines and Angiogenic Factors in Men with Prostate Cancer (2011) (56)
- Serum organochlorine levels and history of lactation in Egypt. (2003) (55)
- Biomarker expression patterns that correlate with high grade features in treatment naive, organ-confined prostate cancer (2008) (54)
- Obesity, Weight Gain, and Risk of Biochemical Failure among Prostate Cancer Patients following Prostatectomy (2005) (54)
- Initial Modulation of the Tumor Microenvironment Accounts for Thalidomide Activity in Prostate Cancer (2007) (53)
- Role of CPS1 in Cell Growth, Metabolism, and Prognosis in LKB1-Inactivated Lung Adenocarcinoma (2017) (52)
- Circulating CD20 and CD52 in patients with non‐Hodgkin's lymphoma or Hodgkin's disease (2003) (51)
- Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors (2014) (50)
- Evidence That Transfer of Functional p53 Protein Results in Increased Apoptosis in Prostate Cancer (2004) (50)
- Colocalized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K/Akt/mTOR pathway. (2014) (50)
- Clinical and Biomarker Correlates of Androgen-Independent, Locally Aggressive Prostate Cancer with Limited Metastatic Potential (2004) (50)
- ST8SIA1 Regulates Tumor Growth and Metastasis in TNBC by Activating the FAK–AKT–mTOR Signaling Pathway (2018) (48)
- Sequential Linearization of Empirical Likelihood Constraints with Application to U-Statistics (1996) (48)
- Linkage disequilibrium analysis in Australian haemochromatosis patients indicates bipartite association with clinical expression. (1999) (47)
- A Dose-finding Study of Aspirin for Chemoprevention Utilizing Rectal Mucosal Prostaglandin E2 Levels as a Biomarker (2002) (47)
- Prospective study of incidence and severity of epiphora and canalicular stenosis in patients with metastatic breast cancer receiving docetaxel. (2006) (46)
- Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes (2015) (45)
- Spatial and temporal analysis of Ross River virus disease patterns at Maroochy Shire, Australia: association between human morbidity and mosquito (Diptera: Culicidae) abundance. (1999) (44)
- Influence of Biospecimen Variables on Proteomic Biomarkers in Breast Cancer (2014) (43)
- Targeting the interleukin-11 receptor α in metastatic prostate cancer: A first-in-man study (2015) (43)
- Frequency of mesenchymal‐epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide‐3‐kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer (2013) (43)
- Lead-time trajectory of CA19-9 as an anchor marker for pancreatic cancer early detection. (2020) (42)
- Relationship between epidemiologic risk factors and breast cancer recurrence. (2007) (42)
- Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide. (2018) (41)
- Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer (2016) (41)
- Discovery and horizontal follow-up of an autoantibody signature in human prostate cancer (2015) (40)
- Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapy (2008) (39)
- Diagnostic value of p53 immunohistochemistry in Barrett's esophagus: An endoscopic study (1998) (39)
- p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer (2016) (39)
- CD 38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia (2001) (38)
- Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate cancer? (2005) (34)
- Functional proteomics characterization of residual triple-negative breast cancer after standard neoadjuvant chemotherapy. (2013) (34)
- Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy (2020) (34)
- Geographical Clustering of Pancreatic Cancers in the Northeast Nile Delta Region of Egypt (2006) (34)
- Bayesian hierarchical structured variable selection methods with application to molecular inversion probe studies in breast cancer (2014) (33)
- A dose-finding study of aspirin for chemoprevention utilizing rectal mucosal prostaglandin E(2) levels as a biomarker. (2002) (31)
- Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours (2002) (31)
- Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities. (1999) (31)
- SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer. (2015) (29)
- A randomized phase 2 study of MK-2206 versus everolimus in refractory renal cell carcinoma (2017) (29)
- KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in mice. (2018) (27)
- The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes. (2013) (27)
- Integrative Bayesian Analysis of High-Dimensional Multi-platform Genomics Data (2012) (27)
- Redirecting T-Cell Specificity to EGFR Using mRNA to Self-limit Expression of Chimeric Antigen Receptor (2016) (27)
- Cytokines and angiogenic factors in patients with metastatic renal cell carcinoma treated with interferon-alpha: association of pretreatment serum levels with survival. (2009) (26)
- Therapy of multidrug resistant human prostate tumors in the prostate of nude mice by simultaneous targeting of the epidermal growth factor receptor and vascular endothelial growth factor receptor on tumor‐associated endothelial cells (2006) (26)
- miRNA–target gene regulatory networks: A Bayesian integrative approach to biomarker selection with application to kidney cancer (2015) (26)
- Association between plasma diacetylspermine and tumor spermine synthase with outcome in triple negative breast cancer. (2019) (26)
- Dicarbonyl/l-Xylulose Reductase: A Potential Biomarker Identified by Laser-Capture Microdissection-Micro Serial Analysis of Gene Expression of Human Prostate Adenocarcinoma (2007) (25)
- Merging microarray data, robust feature selection, and predicting prognosis in prostate cancer (2006) (23)
- Levels of soluble HLA-I and β2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy (2007) (23)
- Epithelial to mesenchymal transition is associated with rapamycin resistance (2015) (23)
- A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial. (2002) (23)
- Immediate versus staged urethrectomy in patients at high risk of urethral recurrence: is there a benefit to either approach? (2006) (22)
- Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung Adenocarcinoma. (2017) (22)
- Randomized phase II study of sorafenib with or without low-dose IFN in patients with metastatic renal cell carcinoma (2007) (21)
- Interaction of Granulocytopenia and Construction Activity as Risk Factors for Nosocomial Invasive Filamentous Fungal Disease in Patients With Hematologic Disorders (1990) (21)
- Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes (2019) (21)
- Copy Number Imbalances between Screen- and Symptom-Detected Breast Cancers and Impact on Disease-Free Survival (2011) (20)
- Functional proteomics characterization of residual breast cancer after neoadjuvant systemic chemotherapy. (2013) (19)
- A Bayesian Semiparametric Survival Model with Longitudinal Markers (2010) (19)
- Association between germline single nucleotide polymorphisms in the PI3K-AKT-mTOR pathway, obesity, and breast cancer disease-free survival (2014) (19)
- Joint Effect of Mutagen Sensitivity and Insulin-Like Growth Factors in Predicting the Risk of Developing Secondary Primary Tumors and Tumor Recurrence in Patients with Head and Neck Cancer (2006) (19)
- Differences in Gene and Protein Expression and the Effects of Race/Ethnicity on Breast Cancer Subtypes (2013) (18)
- Integrative network-based Bayesian analysis of diverse genomics data (2013) (18)
- Combined laser capture microdissection and serial analysis of gene expression from human tissue samples (2005) (18)
- Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancer (2013) (18)
- Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neck (2020) (18)
- Soluble ErbB3 Levels in Bone Marrow and Plasma of Men with Prostate Cancer (2008) (17)
- In vivo imaging of prostate cancer involving bone in a mouse model (2007) (17)
- Circulating CD 20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significance (2003) (17)
- WISP1 is associated to advanced disease, EMT and an inflamed tumor microenvironment in multiple solid tumors (2019) (16)
- Whole Genome-Derived Tiled Peptide Arrays Detect Prediagnostic Autoantibody Signatures in Non-Small-Cell Lung Cancer. (2019) (16)
- PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma (2021) (16)
- A Bayesian screening approach for hepatocellular carcinoma using multiple longitudinal biomarkers (2018) (16)
- Fitting Genetic Models to Twin Data with Binary and Ordered Categorical Responses: A Comparison of Structural Equation Modelling and Bayesian Hierarchical Models (2003) (16)
- Genetic variants in the vitamin D pathway and breast cancer disease-free survival. (2013) (16)
- Model averaging strategies for structure learning in Bayesian networks with limited data (2012) (15)
- A Bayesian predictive model for imaging genetics with application to schizophrenia (2016) (15)
- How to get the most from microarray data: advice from reverse genomics (2014) (14)
- ATM function and its relationship with ATM gene mutations in chronic lymphocytic leukemia with the recurrent deletion (11q22.3-23.2) (2016) (13)
- Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment (2022) (13)
- Personalized Integrated Network Modeling of the Cancer Proteome Atlas (2018) (13)
- LILRB4 expression in chronic myelomonocytic leukemia and myelodysplastic syndrome based on response to hypomethylating agents (2020) (12)
- Pilot trial of bone‐targeted therapy with zoledronate, thalidomide, and interferon‐γ for metastatic renal cell carcinoma (2006) (12)
- Quantification of Mineralized Bone Response to Prostate Cancer by Noninvasive In Vivo μCT and Non-Destructive Ex Vivo μCT and DXA in a Mouse Model (2010) (12)
- Bayesian graphical network analyses reveal complex biological interactions specific to Alzheimer's disease. (2015) (12)
- Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with radical prostatectomy. (2006) (11)
- iDINGO—integrative differential network analysis in genomics with Shiny application (2017) (11)
- aPCoA: covariate adjusted principal coordinates analysis (2020) (10)
- Idelalisib Impacts Cell Growth through Inhibiting Translation-Regulatory Mechanisms in Mantle Cell Lymphoma (2016) (10)
- Analysis of melanoma onset: assessing familial aggregation by using estimating equations and fitting variance components via Bayesian random effects models. (2004) (9)
- A Bayesian integrative approach for multi‐platform genomic data: A kidney cancer case study (2017) (9)
- Interaction of granulocytopenia and construction activity as risk factors for nosocomial invasive filamentous fungal disease in patients with hematologic disorders. (1990) (8)
- Predictive classification of correlated targets with application to detection of metastatic cancer using functional CT imaging (2015) (8)
- Advances in statistical bioinformatics : models and integrative inference for high-throughput data (2013) (8)
- Randomized phase II CTEP study of MK2206 versus everolimus in VEGF inhibitor refractory renal cell carcinoma patients. (2013) (8)
- Frequency of MET and PIK3CA copy number elevation and correlation with outcome in early stage breast cancer (2013) (8)
- A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening (2015) (8)
- Genomic copy number imbalances associated with bone and non-bone metastasis of early-stage breast cancer (2013) (8)
- Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer (2018) (7)
- Bayesian mixture models for complex high dimensional count data in phage display experiments (2007) (7)
- Extracellular and intracellular mechanisms that mediate the metastatic activity of exogenous osteopontin (2009) (7)
- SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas. (2021) (7)
- A MYC-Driven Plasma Polyamine Signature for Early Detection of Ovarian Cancer (2021) (7)
- A System-Level Approach to Improve the Uptake of Antiestrogen Preventive Therapy among Women with Atypical Hyperplasia and Lobular Cancer In Situ (2018) (7)
- Semiparametric Bayesian Inference for Phage Display Data (2013) (7)
- Prognostic Gene Signature Identification Using Causal Structure Learning: Applications in Kidney Cancer (2015) (6)
- Low-Dose Decitabine versus Low-Dose Azacitidine in Lower-Risk MDS (2022) (6)
- Bayesian compositional regression with structured priors for microbiome feature selection (2020) (6)
- Enhanced suppression of prostate tumor growth by combining C-CAM1 gene therapy and angiogenesis inhibitor TNP-470 (2002) (6)
- Bayesian Mixture Models for Gene Expression and Protein Profiles (2006) (6)
- Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer☆ (2016) (6)
- Biostatistical approaches for modeling longitudinal and event time data. (2002) (5)
- Building networks with microarray data. (2010) (5)
- Is hepatic iron the cause of raised serum transaminases in haemochromatosis (1998) (5)
- Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN‐RS‐T) and myelodysplastic syndrome with ring sideroblasts (MDS‐RS) (2021) (5)
- Compositional zero-inflated network estimation for microbiome data (2020) (5)
- Applications and Issues for Tissue Arrays in Target and Drug Discovery (2005) (5)
- Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis (2020) (5)
- A blood-based polyamine signature associated with MEN1 duodenopancreatic neuroendocrine tumor progression. (2021) (5)
- Erratum: Ability to generate patient-derived breast cancer xenografts is enhanced in chemoresistant disease and predicts poor patient outcomes (PLoS ONE (2015) 10:9 (e0136851) DOI: 10.1371/journal.pone.0136851) (2016) (5)
- Application of Gene Shaving and Mixture Models to Cluster Microarray Gene Expression Data (2007) (5)
- Performance determinants of unsupervised clustering methods for microbiome data (2021) (4)
- Prospective study of incidence and severity of epiphora and canalicular stenosis in patients with metastatic breast cancer receiving docetaxel. (2006) (4)
- Myelodysplastic/ Myeloproliferative Neoplasms-Unclassifiable (MDS/MPN-U) with Isolated Isochromosome 17q Represents a Distinct Clinico-Biologic Subset: A Multi-institutional Collaborative Study from the Bone Marrow Pathology Group (2021) (4)
- Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal Cancer (2021) (4)
- Employing the treatment‐free interval of intermittent androgen ablation to screen candidate prostate cancer therapies (2007) (4)
- Unbiased estimation of biomarker panel performance when combining training and testing data in a group sequential design (2016) (4)
- Bagged gene shaving for the robust clustering of high-throughput data (2010) (4)
- Bayesian hierarchical structured variable selection methods with application to MIP studies in breast cancer. (2014) (4)
- Type I interferon upregulation and deregulation of genes involved in monopoiesis in chronic myelomonocytic leukemia. (2021) (4)
- Correction: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes (2016) (4)
- CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diabetes. (2020) (4)
- An Efficient Nonparametric Estimate for Spatially Correlated Functional Data (2019) (4)
- Long-term results of fi rst salvage treatment in CLL patients treated initially with FCR ( fl udarabine , cyclophosphamide , rituximab ) (2014) (3)
- Bayesian inference of hub nodes across multiple networks (2018) (3)
- Demographic, clinical, and geographical factors associated with lack of receipt of physician recommended chemotherapy in women with breast cancer in Texas (2019) (3)
- Identification of Biomarkers in Classification and Clustering of High-Throughput Data (2006) (3)
- CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop (2021) (3)
- U-Curved Relation Between Total Fasting Serum Cholesterol and Hostility: A Population-Based Study (2001) (3)
- Cytoplasmic Cyclin E Expression Predicts for Response to Neoadjuvant Chemotherapy in Breast Cancer (2019) (3)
- Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment (2021) (3)
- Presurgical bevacizumab in patients with metastatic clear cell renal cell carcinoma: A phase II study (2008) (3)
- Advances in Statistical Bioinformatics: Index (2013) (2)
- Models for Probability of Under- and Overexpression: The POE Scale (2006) (2)
- Statistical Methods for Biomarker Discovery Using Mass Spectrometry (2007) (2)
- Performance determinants of unsupervised clustering methods for microbiome data (2022) (2)
- Impact of low estrogen- and progesterone-receptor expression on survival outcomes in breast cancers previously classified as triple-negative breast cancers. (2011) (2)
- Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer (2022) (2)
- The Effect of Initial Therapy Choice in Determining Long Term Survival in Patients with Chronic Lymphocytic Leukemia (CLL). (2006) (2)
- The changing role of liver biopsy in hereditary haemochromatosis after the cloning of the HFE gene (1998) (2)
- miRNA Target Gene Identification: Sourcing miRNA Target Gene Relationships for the Analyses of TCGA Illumina MiSeq and RNA-Seq Hiseq Platform Data (2014) (2)
- Bayesian decision theoretic multiple comparison procedures: An application to phage display data (2013) (2)
- A Framework for Mediation Analysis with Multiple Exposures, Multivariate Mediators, and Non-Linear Response Models (2020) (2)
- Improved detection of hepatocellular carcinoma using a longitudinal α -fetoprotein screening algorithm (2016) (2)
- Phase II study of salvage dose-dense chemotherapy in patients with disseminated non-seminomatous germ cell tumors (NSGCT): Final results (2001) (1)
- Abstract CT-03: Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer (2012) (1)
- Exploiting induced vulnerability to overcome PARPi resistance and clonal heterogeneity in BRCA mutant triple-negative inflammatory breast cancer. (2022) (1)
- Abstract PR-09: Low-fat diet reduces NF-κB regulated inflammatory cytokines and angiogenic factors in plasma of men with prostate cancer (2010) (1)
- Cytokines and angiogenic factors in metastatic renal cell cancer: Association of pretreatment serum levels with survival. (2009) (1)
- Abstract 3528: Quantitation of ATM function in primary CLL cells. (2013) (1)
- How to get the most from microarray data: advice from reverse genomics (2014) (1)
- Transcriptomic Signatures of Hypomethylating Agent Failure in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia. (2022) (1)
- Bayesian hierarchical quantile regression with application to characterizing the immune architecture of lung cancer. (2022) (1)
- p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer (2016) (1)
- Soluble ErbB 3 Levels in BoneMarrow and Plasma of Men with Prostate Cancer (2008) (1)
- Cooperation between KDM6B overexpression and TET2 deficiency in the pathogenesis of chronic myelomonocytic leukemia (2022) (1)
- 2380. Fecal Collinsella Abundance is Negatively Associated with Toxin A/B Production in Cancer Patients with Clostridioides difficile (2019) (1)
- SIFORM: shared informative factor models for integration of multi-platform bioinformatic data (2016) (1)
- A blood-based metabolite panel for distinguishing ovarian cancer from benign pelvic masses. (2022) (1)
- ProgPerm: Progressive permutation for a dynamic representation of the robustness of microbiome discoveries (2020) (1)
- Investigating protein patterns in human leukemia cell line experiments: A Bayesian approach for extremely small sample sizes (2020) (1)
- Abstract 2775: CPS1 as a therapeutic target and prognostic indicator in LKB1-inactivated lung adenocarcinoma (2017) (1)
- A machine learning-based method for automatically identifying novel cells in annotating single-cell RNA-seq data (2022) (1)
- Coordinated modulation of sonic hedgehog (Shh) signaling and androgen receptor (AR) in the prostate tumor microenvironment by chemo-hormonal therapy (2007) (1)
- A phase II study of alternating dose-dense chemotherapy in patients with poor-prognosis disseminated non-seminomatous germ cell tumors (NSGCT): Final results (2001) (1)
- Integrative network-based Bayesian analysis of diverse genomics data (2013) (1)
- Bayesian Functional Mixed Models for Survival Responses with Application to Prostate Cancer (2015) (1)
- 1424: A Robust Algorithm for Calculating PSA Doubling Time (PSADT) (2007) (1)
- untreated patients with chronic lymphocytic leukemia Prognostic nomogram and index for overall survival in previously (2013) (1)
- Abstract 3271: The association between germline genetic variants in the PI3K-AKT-mTOR pathway and breast cancer disease free survival (2014) (0)
- Personalized Integrated Network Modeling of the Cancer Proteome Atlas (2018) (0)
- Investigation of ethnic differences in the prevalence of chromosomal number aberrations of luminal and triple-negative breast cancers associated with risk of recurrence. (2010) (0)
- Abstract 408: ATM function and mutation in CLL 11q deletion samples (2016) (0)
- Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation (2019) (0)
- Sparse tree-based clustering of microbiome data to characterize microbiome heterogeneity in pancreatic cancer. (2020) (0)
- ProgPerm: Progressive permutation for a dynamic representation of the robustness of microbiome discoveries (2021) (0)
- Abstract P076: Contribution of the microbiome to a metabolomic signature predictive of risk for pancreatic cancer (2023) (0)
- Abstract P013: Impact of blood-based biomarkers for predicting lung cancer mortality in the PLCO cohort (2023) (0)
- NExUS: Bayesian simultaneous network estimation across unequal sample sizes (2018) (0)
- Biology of Human Tumors In fl uence of Biospecimen Variables on Proteomic Biomarkers in Breast Cancer (2014) (0)
- Easy NanoString nCounter data analysis with the NanoTube (2022) (0)
- Abstract 4736: ADAMs: potential biomarkers and oncotargets in breast cancer (2017) (0)
- Abstract 2875: Knockout of ST8SIA1 inhibits tumorigenesis in triple negative breast cancer by inducing PTEN and ganglioside GM1 mediated tumor growth arrest (2017) (0)
- Prognostic value of single nucleotide polymorphisms (SNPs) of candidate genes associated with inflammation in early-stage breast cancer. (2011) (0)
- Von Hippel-Lindau gene mutation status is associated with a dichotomous response in primary and metastatic tumors in patients receiving bevacizumab and erlotinib for metastatic renal cell carcinoma (2007) (0)
- Abstract 2898: ST8SIA1 is up-regulated in triple negative breast cancer and its expression is positively correlated withTP53mutations and a cancer stem cell gene signature (2017) (0)
- A semi‐mechanistic dose‐finding design in oncology using pharmacokinetic/pharmacodynamic modeling (2022) (0)
- Sponsor‐involved statistical analyses in Phase III cancer clinical trials (2020) (0)
- PS1325 IDENTIFICATION AND TARGETING OF MOLECULAR SIGNATURES OF HYPOMETHYLATING AGENT RESISTANCE IN MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA (2019) (0)
- Abstract P2-07-06: Cumulative copy number imbalances after neoadjuvant chemotherapy residual breast tumor is an independent predictor of relapse (2019) (0)
- Abstract 1496: Epithelial to mesenchymal transition and rapamycin sensitivity in cancer cell lines. (2013) (0)
- Causal Models, Prediction, and Extrapolation in Cell Line Perturbation Experiments (2022) (0)
- Correction to: Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group (2021) (0)
- Initial Modulation of the TumorMicroenvironment Accounts for ThalidomideActivity in Prostate Cancer (2007) (0)
- Molecular Cancer apeutics linical Development amycin Regulates Stearoyl CoA Desaturase 1 Ther ression in Breast Cancer (2010) (0)
- Demographic, clinical, and geographical factors associated with lack of receipt of physician recommended chemotherapy in women with breast cancer in Texas (2019) (0)
- MDS-439: A Simplified Three-Marker Panel for Myelodysplastic Syndrome Prognostic Outperforms the Well-Established Revised International Prognostic Scoring Systems (IPSS-R) (2021) (0)
- Abstract B84: The association between germline genetic variants in the PI3K pathway and PI3K mutations in breast tumors. (2012) (0)
- For Peer Review Genetic variants in the vitamin D pathway and breast cancer disease-free survival (2012) (0)
- Integration of specific copy number imbalances and prediction models of early-stage breast cancer recurrence. (2010) (0)
- Abstract LB-195: A double-blind randomized controlled multisite trial evaluating tissue effects of preoperative finasteride in clinically organ-confined prostate cancer: Pathologic outcomes. (2013) (0)
- Web Supplementary Material for “A Bayesian integrative approach for multi-platform genomic data: A kidney cancer case study” (2016) (0)
- A unified mediation analysis framework for integrative cancer proteogenomics with clinical outcomes (2023) (0)
- Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer (2012) (0)
- Association of gene copy number alterations in formalin-fixed, paraffin-embedded tumors with prognostic molecular and pathologic tumor subtypes in early-stage breast cancer. (2010) (0)
- Abstract P6-07-26: ST8SIA1 is over-expressed in triple negative breast cancer and associated with p53 mutations (2017) (0)
- Biomarkers of response to Akt inhibitor MK-2206 in breast cancer. (2012) (0)
- Demographic, clinical and geographical factors associated with lack of receipt of recommended chemotherapy. (2018) (0)
- Relationship between differences in RNA or protein expression and the effects of race/ethnicity on breast cancer outcomes. (2011) (0)
- Epidemiological risk factors for breast cancer recurrence according to estrogen and progesterone receptor status (2007) (0)
- Impact of Hemoglobin Level As a Continuous Variable in Calculating Prognosis in MDS: Incorporation into LSC4 and IPSS-R (2020) (0)
- Evolutionary Action Score of TP53 Mutations: Integrated Clinico-pathologic And Protein Structural Analysis in Myelodysplastic Syndromes (2020) (0)
- Epithelial-mesenchymal transition confers resistance to rapamycin (2011) (0)
- Combined Beta Metric for Unsupervised Clustering of Microbiome Data (2020) (0)
- Abstract 2607: Genetic variants in the vitamin D pathway and breast cancer disease free survival (2012) (0)
- Advances in Statistical Bioinformatics: Plate section (2013) (0)
- Imaging , Diagnosis , Prognosis Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer (2011) (0)
- Erratum: Diet modification and metformin have a beneficial effect in a fly model of obesity and mucormycosis (PLoS ONE (2014) 9:9 (e108635) DOI: 10.1371/journal.pone.0108635) (2014) (0)
- Downregulation of UBA1 in Myelodysplastic Syndrome (2022) (0)
- Abstract P2-05-08: p53 deficiency enhances metastatic potential of triple negative breast cancer by promoting growth in primary and metastatic sites (2016) (0)
- 250 ORAL Presurgical treatment of metastatic renal cell carcinoma patients with bevacizumab and erlotinib: preliminary efficacy and biomaker data (2006) (0)
- Clinical, epidemiologic and molecular factors as predictors of time to biochemical failure among prostatectomy patients. (2005) (0)
- Differential gene expression in preoperative study of selenium and vitamin E chemoprevention in prostate cancer (2007) (0)
- Gene Selection for the Identification of Biomarkers in High- Throughput Data (2010) (0)
- Clonal dominance defines metastatic dissemination in pancreatic cancer (2022) (0)
- Using presurgical sunitinib to select patients with newly diagnosed metastatic clear cell renal cell carcinoma for cytoreductive nephrectomy: A phase II study. (2013) (0)
- Analysis of Melanoma Onset: Assessing Familial Aggregation by Using Estimating Equations and Fitting Variance Components via Bayesian Random Effects Models (2004) (0)
- Advances in Statistical Bioinformatics: Preface (2013) (0)
- Supplementary material for: Investigating Protein Patterns in Human Leukemia Cell Line Experiments: A Bayesian Approach for Extremely Small Sample Sizes (2019) (0)
- Advances in Statistical Bioinformatics: Bayesian Graphical Models for Integrating Multiplatform Genomics Data (2013) (0)
- A mesenchymal/stem cell predictor of survival of patients with malignant gliomas. (2010) (0)
- Estimating Shared Copy Number Aberrations for Array CGH Data: The Linear-Median Method (2010) (0)
- CNGPLD: case-control copy-number analysis using Gaussian process latent difference (2022) (0)
- Characterization of patient-derived breast cancer xenografts demonstrates molecular evolution (2011) (0)
- Abstract A61: Prognostic relevance of genome-wide association studies-identified single nucleotide polymorphisms in primary breast cancer (2011) (0)
- Abstract 1929: ST8SIA1 is a novel therapeutic target in TNBC: Regulates FAK-PI3K-AKT-mTOR signaling to promote tumor growth and metastasis (2018) (0)
- Inhibition of MDM2 Improves the Therapeutic Effect of Hypomethylating Agents in Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML) (2021) (0)
- A Dose-finding Study of Aspirin for Chemoprevention Utilizing Rectal Mucosal Prostaglandin E 2 Levels as a Biomarker 1 (2002) (0)
- A Bayesian Mixture Approach to the Classification of Proteomic Profiles (2006) (0)
- A Comprehensive Search of Non-Canonical Proteins in Non-Small Cell Lung Cancer and Their Impact on the Immune Response (2022) (0)
- Supplementary material for Estimating Copy Numbers for Shared Array CGH Data: the Linear-Median Method (2010) (0)
- Abstract P066: Blood-based proteomic signatures associated with MEN1-related duodenopancreatic neuroendocrine tumor progression (2023) (0)
- Risk Factors Associated with Severe Clostridioides difficile Infection in Patients with Cancer (2022) (0)
- Transcriptomic Signitures of Azacitidine (AZA) and Decitabine (DAC) Resistance in MDS and CMML (2021) (0)
- Abstract 162: Biomarker identification of residual triple negative breast cancer (TNBC) after standard neoadjuvant chemotherapy (NCT) (2012) (0)
- OP-CBIO120355 149..159 (2013) (0)
- Evolutionary Action (EA) Score of TP53 Mutations Defines Prognostic Subsets within TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia (2019) (0)
- Abstract 1186: Patient-derived breast cancer xenografts demonstrate molecular evolution in the phosphatidylinositol 3-kinase pathway upon engraftment (2014) (0)
- 54. Tool for filtering FFPE sequence artifacts from paired-end sequencing data (2020) (0)
- Chemotherapy and Abdominal Wall Closure Technique Increase the Probability of Postoperative Ventral Incisional Hernia in Patients With Colon Cancer (2020) (0)
- High risk CNIs, race and early stage breast cancer (2013) (0)
- MDM2 antagonist improves therapeutic activity of azacitidine in myelodysplastic syndromes and chronic myelomonocytic leukemia (2022) (0)
- lymphocytic leukemia and is of prognostic significance Circulating CD20 is detectable in the plasma of patients with chronic (2013) (0)
- Advances in Statistical Bioinformatics: Methods for the Analysis of Copy Number Data in Cancer Research (2013) (0)
This paper list is powered by the following services:
Other Resources About Kim-Anh Do
What Schools Are Affiliated With Kim-Anh Do?
Kim-Anh Do is affiliated with the following schools:
